|
|
In Vitro Diagnostics Industry in China: Current Status and Development Strategies |
Qian GAO1,2,Hong JIANG1,2,Yu-bao CHEN3,4,**() |
1. Wuhan Library of Chinese Academy of Sciences, Wuhan 430071, China 2. Hubei Key Laboratory of Big Data in Science and Technology, Wuhan 430071, China 3. Institute of Laboratory Animal Sciences, CAMS&PUMC, Beijing 100083, China 4. Chinese Society of Biotechnology, Beijing 100101, China |
|
|
Abstract In vitro diagnostics plays an important role in the process of disease diagnosis and treatment, which is referred to as the doctor’s eye. In the context of the unprecedented increase in people’s attention to life and health caused by the COVID-19 pandemic, in vitro diagnostics has showed an explosive growth as an important part of the health industry. For the field of in vitro diagnostics, the developing status of the world and China was summarized. Particularly, the market situation, competition landscape, and national-made situation were analyzed. The problems in the current stage of in-vitro diagnostics industry in China were analyzed, and then the corresponding suggestions and countermeasures were put forward from some aspects, including making a breakthrough in original innovation, strengthening the guarantee of funds, building a complete industrial chain, and strengthening personnel training.
|
Received: 10 May 2022
Published: 04 November 2022
|
|
Corresponding Authors:
Yu-bao CHEN
E-mail: chenyubao@cnilas.org
|
|
|
[1] |
徐芳萍, 黄慧媛, 褚淑贞. 我国体外诊断试剂产业发展现状、问题及对策. 中国医药工业杂志, 2019, 50(11): 1367-1373.
|
|
|
[1] |
Xu F P, Huang H Y, Chu S Z. Development status and problems of IVD reagent industry in China. Chinese Journal of Pharmaceuticals, 2019, 50(11): 1367-1373.
|
|
|
[2] |
袁银池, 赵晓勤, 陈大明, 等. 体外诊断试剂研发及市场发展概况. 生物产业技术, 2017(4): 16-24.
|
|
|
[2] |
Yuan Y C, Zhao X Q, Chen D M, et al. The development situation of research and market in vitro diagnostic reagents. Biotechnology & Business, 2017(4): 16-24.
|
|
|
[3] |
谢兰, 刘冉, 冯娟, 等. 中国分子诊断产业战略研究. 中国工程科学, 2017, 19(2): 29-36.
|
|
|
[3] |
Xie L, Liu R, Feng J, et al. Strategic research on the molecular diagnostics industry in China. Engineering Science, 2017, 19(2): 29-36.
|
|
|
[4] |
王贵明. HSK公司体外诊断试剂质控品互联网平台商业模式创新. 北京: 北京理工大学, 2017.
|
|
|
[4] |
Wang G M. Internet platform business model innovation on IVD QC product of HSK Co. Beijing: Beijing Institute of Technology, 2017.
|
|
|
[5] |
张璐瑶, 朱昕晨, 李文璐. 国产器械崛起,进口替代及国际化是重要发展方向. [2021-09-01]. https://www.xcc.com/newdetail/4349003?category=cyxw.
|
|
|
[5] |
Zhang L Y, Zhu X C, Li W L. Rise of domestic medical device, import substitution and internationalization are two important directions. [2021-09-01]. https://www.xcc.com/newdetail/4349003?category=cyxw.
|
|
|
[6] |
马帅. 新冠检测中长期重塑POCT赛道逻辑. [2021-04-26]. https://t.cj.sina.com.cn/articles/view/7426890874/1baad5c7a00100wz18.
|
|
|
[6] |
Ma S. The Reimagination of POCT track post COVID-19 condition. [2021-04-26]. https://t.cj.sina.com.cn/articles/view/7426890874/1baad5c7a00100wz18.
|
|
|
[7] |
徐偲. 生物试剂行业深度报告. [2021-09-27]. https://cj.sina.com.cn/articles/7426890874/1baad5c7a00100zmuq.
|
|
|
[7] |
Xu C. Biological reagents market in-depth research. [2021-09-27]. https://cj.sina.com.cn/articles/7426890874/1baad5c7a00100zmuq.
|
|
|
[8] |
陈铁林, 王艳. 迈瑞医疗:全球化征程新起点,新赛道蓄势起飞. [2022-01-13]. https://www.hangyan.co/reports/2750646317695895364.
|
|
|
[8] |
Chen T L, Wang Y. Mindray: The process of globalization is progressing, the new track is poised to take off. [2022-01-13]. https://www.hangyan.co/reports/2750646317695895364.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|